225 related articles for article (PubMed ID: 32807475)
1. Comparative analysis of fibrinolytic properties of Alteplase, Tenecteplase and Urokinase in an in vitro clot model of intracerebral haemorrhage.
Keric N; Döbel M; Krenzlin H; Kurz E; Tanyildizi Y; Heimann A; König J; Kempski O; Ringel F; Masomi-Bornwasser J
J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105073. PubMed ID: 32807475
[TBL] [Abstract][Full Text] [Related]
2. Effect of irrigation on fibrinolytic rtPA therapy in a clot model of intracerebral haemorrhage: a systematic in vitro study.
Masomi-Bornwassser J; Freguia F; Müller-Werkmeister H; Kempski O; Giese A; Keric N
Acta Neurochir (Wien); 2018 Jun; 160(6):1159-1165. PubMed ID: 29564653
[TBL] [Abstract][Full Text] [Related]
3. Optimization of Catheter Based rtPA Thrombolysis in a Novel In Vitro Clot Model for Intracerebral Hemorrhage.
Keric N; Masomi-Bornwasser J; Müller-Werkmeister H; Kantelhardt SR; König J; Kempski O; Giese A
Biomed Res Int; 2017; 2017():5472936. PubMed ID: 28459065
[TBL] [Abstract][Full Text] [Related]
4. Systematic Analysis of Combined Thrombolysis Using Ultrasound and Different Fibrinolytic Drugs in an in Vitro Clot Model of Intracerebral Hemorrhage.
Masomi-Bornwasser J; Fabrig O; Krenzlin H; König J; Tanyildizi Y; Kempski O; Ringel F; Keric N
Ultrasound Med Biol; 2021 May; 47(5):1334-1342. PubMed ID: 33549380
[TBL] [Abstract][Full Text] [Related]
5. Comparison of intrathecally administered urokinase, tissue-type plasminogen activator, and combination of urokinase and lysine-plasminogen for clot lysis after experimental subarachnoid hemorrhage in dogs.
Kajimoto Y; Ohta T; Kuroiwa T
Neurosurgery; 1997 Mar; 40(3):572-7. PubMed ID: 9055298
[TBL] [Abstract][Full Text] [Related]
6. Urokinase, a promising candidate for fibrinolytic therapy for intracerebral hemorrhage.
Tan Q; Chen Q; Niu Y; Feng Z; Li L; Tao Y; Tang J; Yang L; Guo J; Feng H; Zhu G; Chen Z
J Neurosurg; 2017 Feb; 126(2):548-557. PubMed ID: 27104852
[TBL] [Abstract][Full Text] [Related]
7. Combination of ultrasound and rtPA enhances fibrinolysis in an In Vitro clot system.
Masomi-Bornwasser J; Winter P; Müller-Werkmeister H; Strand S; König J; Kempski O; Ringel F; Kantelhardt SR; Giese A; Keric N
PLoS One; 2017; 12(11):e0188131. PubMed ID: 29145482
[TBL] [Abstract][Full Text] [Related]
8. In vitro simulation of therapeutic thrombolysis with microtiter plate clot-lysis assay.
Stief TW
Clin Appl Thromb Hemost; 2006 Jan; 12(1):21-32. PubMed ID: 16444431
[TBL] [Abstract][Full Text] [Related]
9. 3K3A-Activated Protein C Variant Does Not Interfere With the Plasma Clot Lysis Activity of Tenecteplase.
Mukherjee P; Lyden P; Fernández JA; Davis TP; Pryor KE; Zlokovic BV; Griffin JH
Stroke; 2020 Jul; 51(7):2236-2239. PubMed ID: 32568648
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic efficacy of Amediplase, Tenecteplase and scu-PA in different external plasma clot lysis models: sensitivity to the inhibitory action of thrombin activatable fibrinolysis inhibitor (TAFI).
Guimarães AH; Barrett-Bergshoeff MM; Criscuoli M; Evangelista S; Rijken DC
Thromb Haemost; 2006 Sep; 96(3):325-30. PubMed ID: 16953274
[TBL] [Abstract][Full Text] [Related]
11. Doppler sonography enhances rtPA-induced fibrinolysis in an in vitro clot model of spontaneous intracerebral hemorrhages.
Masomi-Bornwasser J; Winter P; Neulen A; Kantelhardt SR; König J; Kempski O; Ringel F; Keric N
PLoS One; 2019; 14(1):e0210810. PubMed ID: 30653589
[TBL] [Abstract][Full Text] [Related]
12. Urokinase versus Alteplase for intraventricular hemorrhage fibrinolysis.
Gaberel T; Montagne A; Lesept F; Gauberti M; Lemarchand E; Orset C; Goulay R; Bertrand T; Emery E; Vivien D
Neuropharmacology; 2014 Oct; 85():158-65. PubMed ID: 24846802
[TBL] [Abstract][Full Text] [Related]
13. Preliminary findings of the minimally-invasive surgery plus rtPA for intracerebral hemorrhage evacuation (MISTIE) clinical trial.
Morgan T; Zuccarello M; Narayan R; Keyl P; Lane K; Hanley D
Acta Neurochir Suppl; 2008; 105():147-51. PubMed ID: 19066101
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of the efficacy and specificity of tissue plasminogen activator and pro-urokinase: demonstration of synergism and of different thresholds of non-selectivity.
Gurewich V; Pannell R
Thromb Res; 1986 Oct; 44(2):217-28. PubMed ID: 3097872
[TBL] [Abstract][Full Text] [Related]
15. Differential fibrinolytic properties of the recombinant plasminogen activator BM 06.022 in human plasma and blood clot systems in vitro.
Martin U; Sponer G; Strein K
Blood Coagul Fibrinolysis; 1993 Apr; 4(2):235-42. PubMed ID: 8388740
[TBL] [Abstract][Full Text] [Related]
16. Fibrinolytic mechanism, biochemistry, and preclinical pharmacology of recombinant prourokinase.
Credo RB; Burke SE
J Vasc Interv Radiol; 1995; 6(6 Pt 2 Suppl):8S-18S. PubMed ID: 8770836
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound combined with urokinase under key-shaped bone window enhances blood clot lysis in an in vitro model of spontaneous intracerebral hemorrhage.
Xu L; Yang Q; Gong J; Wang J; Xiong W; Liu L; Liu Y; Zhou W; Sun C; Liang Y; Wang Y; Xiang Y; Deng Y; Cui M
PLoS One; 2024; 19(5):e0304398. PubMed ID: 38814913
[TBL] [Abstract][Full Text] [Related]
18. Alteplase and tenecteplase: applications in the peripheral circulation.
Semba CP; Sugimoto K; Razavi MK;
Tech Vasc Interv Radiol; 2001 Jun; 4(2):99-106. PubMed ID: 11981795
[TBL] [Abstract][Full Text] [Related]
19. Future perspectives on the fibrinolytic therapy of intracerebral hemorrhages.
Thiex R
Cent Nerv Syst Agents Med Chem; 2011 Jun; 11(2):150-6. PubMed ID: 21521167
[TBL] [Abstract][Full Text] [Related]
20. Minimally invasive evacuation of spontaneous intracerebral hemorrhage using sonothrombolysis.
Newell DW; Shah MM; Wilcox R; Hansmann DR; Melnychuk E; Muschelli J; Hanley DF
J Neurosurg; 2011 Sep; 115(3):592-601. PubMed ID: 21663412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
